December 3, 2020 1:00 am / 2:00 am

RSVP at https://tinyurl.com/EHS411

About the lecture: This seminar will explore the inhibition of cancer progression by omega-3 polyunsaturated fatty acids, and illustrate how and why investigators choose research topics, and the roles of funding agencies and scientific journals in this process.

About the speaker: Oliver Hankinson received his PhD in genetics from Cambridge University, England, in 1972. He did postdoctoral research in mammalian cell genetics at Harvard University, the University of Colorado, and the University of California, Berkeley, before joining the UCLA faculty in 1979. He was Director of the Carcinogenesis program of the UCLA Jonsson Comprehensive Cancer Center from 1994 to 2003, and Vice-Chair for Research of the Department of Pathology from 1997 to 2003. In 2000 he was founding director of the Molecular Toxicology PhD program. Dr. Hankinson was awarded the Society of Toxicology’s 2011 Distinguished Toxicology Award. In 2013, he was elected a fellow of the American Association for the Advancement of Science. In 2019 he was awarded the Society of Toxicology’s annual Education Award.

About the Molecular Toxicology IDP: The thirty faculty of the IDP come from sixteen different departments in the Schools of Public Health, Medicine, Nursing and Engineering, and the College of Letters and Science at UCLA. Areas of particular strength in the program include air pollution toxicology, nanotoxicology, metal toxicity, the environmental causation of Parkinson’s disease, toxico-epigenetics, model organisms & predictive toxicology, and big data & computational toxicology.

*Joint lectures with Mol Tox IDP, supported by the UCLA NIEHS Training Grant in Molecular Toxicology T32ES015457. For more information regarding joint lectures above, please email Dr. Oliver Hankinson at OHank@mednet.ucla.edu.